Robert Ruffolo

Robert Ruffolo

Direktor/Vorstandsmitglied bei ELICIO THERAPEUTICS, INC.

Vermögen: - $ am 31.07.2023

74 Jahre
Health Technology
Commercial Services
Consumer Services

Ursprung des Netzwerks ersten Grades von Robert Ruffolo

EinheitArt der EinheitIndustrie
241
College/University Other Consumer Services 241
220
Non-Profit Organization Miscellaneous Commercial Services 220
Public Company Pharmaceuticals: Major 103
33
Subsidiary Pharmaceuticals: Major 33
Public Company Biotechnology 29
22
Subsidiary Biotechnology 22
Public Company Biotechnology 16
12
Private Company Miscellaneous Commercial Services 12
11
Subsidiary Miscellaneous Commercial Services 11
7
Holding Company Biotechnology 7
7
Holding Company Biotechnology 7
Public Company Pharmaceuticals: Major 7
Unknown 7
7
Holding Company Biotechnology 7
7
Private Company Miscellaneous Commercial Services 7
7
Holding Company Drugstore Chains 7
6
Holding Company Pharmaceuticals: Major 6
6
Holding Company Biotechnology 6
6
Holding Company Pharmaceuticals: Major 6
Extinct Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Robert Ruffolo

UnternehmenSektorVerknüpfte PersonenHauptposition
Medical Specialties

Paul Thomas

Thomas Mathers

Rogério Vivaldi Coelho

Susan Windham-Bannister

Matthew P. Kowalsky

Josias Fantato De Pontes

President

Corporate Officer/Principal

Corporate Officer/Principal

Founder

Corporate Officer/Principal

Comptroller/Controller/Auditor

Massachusetts Institute of Technology College/University

Howard H. Pien

Julian Adams

Jeffrey Peterson

Darrell J. Irvine

Peter DeMuth

Undergraduate Degree

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

Pharmaceuticals: Major

Paul Thomas

Clive Meanwell

Howard H. Pien

Bernard Poussot

Jean-Christophe Tellier

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Jeremy Levin

William H. Koster

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Sales & Marketing

College/University

Allen Nissenson

Philip Johnson

Greg Parekh

Yekaterina Chudnovsky

Undergraduate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Jeremy Levin

Ronald Cohen

Sharon Mates

Director/Board Member

Chairman

Chairman

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

Christopher Haqq

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Boston College College/University

Daniel Junius

James Meyers

Robert Radie

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Ivan Philip Gergel

Neil J. Hayward

David Soergel

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

NOVARTIS AG Pharmaceuticals: Major

David Pyott

Pablo Cagnoni

Greg Parekh

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Ivan Philip Gergel

Jeremy Levin

Greg Parekh

Chief Tech/Sci/R&D Officer

Consultant / Advisor

Founder

GILEAD SCIENCES, INC. Biotechnology

James Meyers

Ted Love

James Sapirstein

Corporate Officer/Principal

Director/Board Member

Sales & Marketing

Biotechnology

Clive Meanwell

James Sapirstein

Joseph McCracken

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

BIOVERATIV INC Biotechnology

Geno Germano

Rogério Vivaldi Coelho

Qing Sarah Yuan

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Steven Holtzman

John Maraganore

Annette Matthies

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Berkeley College/University

Karen Wilson

Rachel Haurwitz

Qing Sarah Yuan

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Ted Love

Director/Board Member

Director/Board Member

Director/Board Member

ELI LILLY AND COMPANY Pharmaceuticals: Major

James Sapirstein

Robert Radie

Philip Johnson

Chief Operating Officer

Corporate Officer/Principal

Investor Relations Contact

Pharmaceuticals: Major

Steven Holtzman

John Maraganore

Julian Adams

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The University of Colorado College/University

Pablo Cagnoni

Robin Steele

Robert Windsor

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Pablo Cagnoni

Helen Torley

Ted Love

President

Chief Operating Officer

Chief Tech/Sci/R&D Officer

University of Maryland College/University

Clay Siegall

Sharon Mates

Peter DeMuth

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

IMMUNOGEN, INC. Biotechnology

Daniel Junius

Mark B. Skaletsky

Howard H. Pien

Chief Executive Officer

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Bernard Poussot

Geno Germano

Chief Executive Officer

President

ROCKWELL MEDICAL, INC. Medical Specialties

Allen Nissenson

Robert Radie

Director/Board Member

Chairman

Feinberg School of Medicine College/University

Allen Nissenson

Jeffrey Sherman

Doctorate Degree

Corporate Officer/Principal

Investment Managers

Douglas Cole

Robert Connelly

Private Equity Investor

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Ivan Philip Gergel

Jay Venkatesan

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Paul Wotton

William H. Koster

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Pablo Cagnoni

Douglas Cole

Director/Board Member

Chairman

ANTARES PHARMA, INC. Pharmaceuticals: Major

Paul Wotton

Helen Torley

Chief Executive Officer

Director/Board Member

University of London College/University

Paul Wotton

Neil J. Hayward

Undergraduate Degree

Undergraduate Degree

VELOXIS PHARMACEUTICALS A/S Pharmaceuticals: Major

Paul Wotton

Robert Radie

Director/Board Member

Director/Board Member

Princeton University College/University

Carl Feldbaum

Ronald Cohen

Undergraduate Degree

Undergraduate Degree

ENDO INTERNATIONAL PLC Pharmaceuticals: Major

Ivan Philip Gergel

Carol Ashe

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Investment Managers

John Maraganore

Susan Windham-Bannister

Consultant / Advisor

Consultant / Advisor

MACROGENICS, INC. Pharmaceuticals: Major

John Maraganore

Jean-Christophe Tellier

Chairman

Corporate Officer/Principal

Pharmaceuticals: Major

Ivan Philip Gergel

Clive Meanwell

Chief Tech/Sci/R&D Officer

Director/Board Member

Pharmaceuticals: Major

Ivan Philip Gergel

Evan Tzanis

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

DICE THER Biotechnology

Philip Johnson

Michael Thompson

President

Director/Board Member

Miscellaneous Commercial Services

Ivan Philip Gergel

Robert Radie

Director/Board Member

Director/Board Member

POIT BIOP Pharmaceuticals: Major

Philip Johnson

Michael Thompson

President

Director/Board Member

SPENDSMART NETWORKS, INC. Advertising/Marketing Services

Cary Sucoff

Timothy Boris

Director/Board Member

President

GREENWOOD HALL, INC. Miscellaneous Commercial Services

Cary Sucoff

Timothy Boris

Director/Board Member

Chief Operating Officer

ROCHE HOLDING AG Pharmaceuticals: Major

Clive Meanwell

Bernard Poussot

Director/Board Member

Director/Board Member

Biotechnology

Douglas Cole

Darrell J. Irvine

Director/Board Member

Founder

Statistik

International

Vereinigte Staaten 46
Schweiz 2
Indien 2
Vereinigtes Königreich 2
Dänemark 2

Sektoral

Health Technology 32
Consumer Services 10
Commercial Services 7
Finance 5

Operativ

Director/Board Member 665
Corporate Officer/Principal 237
Independent Dir/Board Member 180
Chief Executive Officer 131
Chairman 123
  1. Börse
  2. Insiders
  3. Robert Ruffolo
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT